CMPX — COMPASS THERAPEUTICS INC

Ownership history in Birchview Capital, LP  ·  3 quarters on record

This page tracks every 13F SEC filing in which Birchview Capital, LP reported a position in COMPASS THERAPEUTICS INC (CMPX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
5.01% (2025 Q4)
Avg. % of fund
2.45%
First filed
2025 Q1
Last filed
2025 Q4
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 1,592,938 +720,000 +82.5% 5.01% $8.6M $5.37
2025 Q3 ADDED 872,938 +848,938 +3537.2% 2.31% $3.1M $3.50
2025 Q1 INITIATED 24,000 — — 0.04% $46K $1.90
% of Fund (quarterly)    CMPX price (monthly, adj. close)

Other funds also holding CMPX

As of 2025 Q4 — sorted by position size

TANG CAPITAL MANAGEMENT LLC 3Y 7Y 4.45% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 3.99% CAXTON CORP 3Y 7Y 3.7% Vivo Capital, LLC 3Y 7Y 3.31% Monashee Investment Management LLC 3Y 7Y 3.03% Seven Fleet Capital Management LP 2.32% Palo Alto Investors LP 3Y 7Y 1.89% ORBIMED ADVISORS LLC 3Y 7Y 1.67% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 1.56% BVF INC/IL 3Y 7Y 1.4%
← Back to Birchview Capital, LP Holdings